Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-04-25

FDA Approved: LAMOTRIGINE — Supplemental Application (Torrent Pharmaceuticals Limited)

View source ↗

Summary

The FDA approved a supplemental application for Lamotrigine from Torrent Pharmaceuticals Limited (ANDA203370). The action updates the product status for this ge…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lamotrigine (lamotrigine)

Snippet

SUPPL AP for LAMOTRIGINE (LAMOTRIGINE)